Pull to refresh
Logo
Daily Brief
Following
Why Sign Up
John V. Brigande

John V. Brigande

Associate Professor, Oregon Hearing Research Center, OHSU

Appears in 1 story

Stories

Gene therapy restores hearing in deaf patients

New Capabilities

Pioneering fetal gene therapy for congenital deafness

Children born profoundly deaf can now hear their parents' voices. A single injection of gene therapy into the inner ear has restored hearing in dozens of patients with genetic deafness, moving some forms of lifelong hearing loss from permanent disability into the treatable category. The effect is rapid—most patients recover hearing within weeks—and sustained over at least two years of follow-up.

Updated Jan 9